Radioactive implant targets pancreatic tumors from the inside
Disease control
Recruiting now
This early study tests a new device called YntraDose™ that delivers a single dose of radiation directly into pancreatic tumors that cannot be removed by surgery. Ten participants will receive the implant along with standard chemotherapy. The main goals are to see if the procedure…
Phase: NA • Sponsor: BetaGlue Therapeutics SpA • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC